Christopher Missling
Chief Executive Officer bij ANAVEX LIFE SCIENCES CORP.
Vermogen: 6 M $ op 31-03-2024
Actieve functies van Christopher Missling
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ANAVEX LIFE SCIENCES CORP. | Director/Board Member | - | - |
Chief Executive Officer | 05-07-2013 | - | |
President | 05-07-2013 | - | |
Corporate Secretary | 05-07-2013 | - | |
Chairman | - | - | |
Director of Finance/CFO | 05-07-2013 | 01-10-2015 | |
Investor Relations Contact | 05-07-2013 | - | |
Treasurer | 05-07-2013 | - |
Loopbaan van Christopher Missling
Eerdere bekende functies van Christopher Missling
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aventis, Inc. | Corporate Officer/Principal | - | - |
IMMUNOGEN, INC. | Director of Finance/CFO | - | - |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Corporate Officer/Principal | - | - |
CURIS, INC. | Director of Finance/CFO | - | - |
Opleiding van Christopher Missling
Ludwig-Maximilians-Universität München | Doctorate Degree |
WHU-Otto Beisheim School of Management | Masters Business Admin |
Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 7 |
Duitsland | 3 |
Operationeel
Director of Finance/CFO | 3 |
Masters Business Admin | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
IMMUNOGEN, INC. | Health Technology |
CURIS, INC. | Health Technology |
ANAVEX LIFE SCIENCES CORP. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Aventis, Inc. | |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Brimberg & Co. LP is a broker/dealer headquartered in New York City. They provide a full array of trading and execution services for their clients. They do not provide any internal research. | Finance |